Risk of second cancer in esophageal squamous cell carcinoma and adenocarcinoma survivors: a population-based analysis in SEER dataset

IF 3 4区医学 Q1 Medicine

Translational gastroenterology and hepatology Pub Date : 2023-10-01 DOI:10.21037/tgh-23-29

Xiaona Qi, Xiaoying Su, Changhong Wang, Qiang Yao, Yuying Fan

引用次数: 0

Abstract

Background: Previous studies have reported increased risk of second cancer in both esophageal squamous cell cancer (ESCC) and esophageal adenocarcinoma (EAC) survivors. This study aimed to examine the risk and influential factors of second cancer in ESCC and EAC patients.

查看原文本刊更多论文

食管鳞状细胞癌和腺癌幸存者的第二癌风险:基于SEER数据集的人群分析

背景:先前的研究报道了食管鳞状细胞癌(ESCC)和食管腺癌(EAC)幸存者患第二癌的风险增加。本研究旨在探讨ESCC和EAC患者发生第二癌的危险及影响因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Translational gastroenterology and hepatology Medicine-Gastroenterology

CiteScore

8.20

自引率

0.00%

发文量

期刊介绍： Translational Gastroenterology and Hepatology (Transl Gastroenterol Hepatol; TGH; Online ISSN 2415-1289) is an open-access, peer-reviewed online journal that focuses on cutting-edge findings in the field of translational research in gastroenterology and hepatology and provides current and practical information on diagnosis, prevention and clinical investigations of gastrointestinal, pancreas, gallbladder and hepatic diseases. Specific areas of interest include, but not limited to, multimodality therapy, biomarkers, imaging, biology, pathology, and technical advances related to gastrointestinal and hepatic diseases. Contributions pertinent to gastroenterology and hepatology are also included from related fields such as nutrition, surgery, public health, human genetics, basic sciences, education, sociology, and nursing.